ESG News For Foster City

The Children’s Inn at the National Institutes of Health (NIH) today announced that Gilead Sciences Inc. has awarded The Inn a $1 million grant to support its renovation and expansion. The grant will fund a welcome center in the new wing of The Inn of Tomorrow, a $50-plus million project for which The Inn recently held a groundbreaking ceremony. As the first point of contact, The Gilead Sciences Welcome Center is designed to ensure young patients from around the world participating in groundbreak

– Gilead Also Included on the Dow Jones Sustainability North America Index; Rankings Reflect Gilead’s Ongoing Commitment to Corporate Responsibility –– DJSI World Highlights the Most Sustainable Companies Around the World Based on Corporate Sustainability Assessment –

HIV/AIDS advocates converge at Evercore ISI HealthCONx Conference in Miami to expose drugmaker’s piggish practices

– The New Report Also Recognized Gilead As the Number One Funder of Organizations Focused on Achieving Health Equity for Key Populations, Including U.S. BIPOC Communities, Transgender Communities and Gay Men –

65 physicians comprise Cohort III, bringing the total to 179 participants in the program’s third year

Protest Wednesday, June 21st, will target drug company CEO at company’s Foster City HQ

Protest Wednesday, June 21st, will target drug company CEO at company’s Foster City HQ

– DJSI World Highlights the Most Sustainable Companies Around the World Based on Corporate Sustainability Assessment –– Ranking Reflects Gilead’s Ongoing Commitment to Corporate Responsibility –

Washington, D.C. protest is one of three PROTESTS targeting Gilead that AHF has set for Thursday, December 1st, with the other two taking place in Miami and Oceanside, CA, all at local Gilead officesAdvocates target Gilead’s insatiable greed and its drug pricing and policies, including illegal restrictions the drug company places for certain pharmacies on access to 340B drug pricing for Gilead’s branded hepatitis C treatments

64 physicians comprise Cohort II, bringing the total to 116 participants in the program’s second year

– Gilead Will Provide up to $5 Million in Global Grant Funding to Immediately Support Public Education and Vaccine Hesitancy Communications, a Public Policy Response and a Global Outbreak Emergency Fund for Community Organizations in Regions with Active Monkeypox Outbreaks –

Gilead Protest, Wednesday, May 18th, 12:00 pm Foster City, CAIn March, Gilead imposed conditions illegally restricting access on 340B drug pricing to its branded hepatitis C treatments when covered entities use outside contract pharmacies. Gilead has the ignominious distinction of being the 15th manufacturer to place similar unlawful restrictions on certain 340B contract pharmacy programs

Gilead Protest, Thursday, May 5th, 12:00 pm Foster City, CAIn March, Gilead imposed conditions illegally restricting access on 340B drug pricing to its branded hepatitis C treatments when covered entities use outside contract pharmacies. Gilead has the ignominious distinction of being the 15th manufacturer to place similar unlawful restrictions on certain 340B contract pharmacy programs

– Funding Will Reach Under-Resourced Communities Most Impacted by the HIV Epidemic and COVID-19 Pandemic –

Gilead Protest, Wed., March 23, 11:00 a.m., Foster City, CA Last week, Gilead imposed conditions illegally restricting access on 340B drug pricing to its branded hepatitis C treatments when covered entities use outside contract pharmacies. Gilead has the ignominious distinction of being the 15th manufacturer to place similar unlawful restrictions on certain 340B contract pharmacy programs

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company will donate 100,000 vials of Veklury® (remdesivir) to help address the recent surge of COVID-19 cases in Indonesia and 3,000 vials of Veklury to help patients hospitalized with COVID-19 in Armenia.“As cases of COVID-19 surge again around the world, and the pandemic continues to affect the lives of so many, we remain focused on ensuring that our medicines can reach patients that need them,” said Johanna Mercier, Chief Commercia

Gilead Sciences, Inc. (Nasdaq: GILD) and the Human Rights Campaign (HRC), the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization, today announced that Gilead will provide a $3.2 million grant over two years to support communities disproportionately impacted by the HIV epidemic in the United States, particularly communities of color. Gilead will directly fund the efforts of the HRC Foundation – HRC’s educational arm – aimed at ending the HIV epidemic